Addressing Reported Pro-Apoptotic Functions of NF-κB: Targeted Inhibition of Canonical NF-κB Enhances the Apoptotic Effects of Doxorubicin

Brian K. Bednarski, Albert S. Baldwin, Hong Jin Kim · 2009

Read Addressing Reported Pro-Apoptotic Functions of NF-κB: Targeted Inhibition of Canonical NF-κB Enhances the Apoptotic Effects of Doxorubicin by Brian K. Bednarski, Albert S. Baldwin, Hong Jin Kim (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006992.txt.

Description

Brian Bednarski, Albert Baldwin, and Hong Jin Kim revisited a cancer signaling protein in PLOS ONE in 2009. NF-κB is a transcription factor that can switch on protective genes in tumor cells. That protective role has been blamed for tumors resisting chemotherapy. Yet some studies claimed the same factor helps the drug doxorubicin kill cells instead.

The team tested targeted inhibition of the canonical NF-κB pathway. Blocking it made doxorubicin's killing effect stronger, not weaker. Their result challenges the reported death-promoting role. It supports pairing NF-κB blockers with standard drugs to break chemoresistance.

Catalog record

CREATORBrian K. Bednarski, Albert S. Baldwin, Hong Jin Kim
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006992

Browse the full library · About the Tower of Babel